SARS-CoV-2 Observational Study
- Conditions
- acute respiratory tract infection
- Registration Number
- NL-OMON29166
- Lead Sponsor
- MC Utrecht
- Brief Summary
none
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 600
•Male or female aged one year or older;
•Consulting face-to-face, online, or telephoning with symptoms of CA-ARTI (upper and or lower), with symptoms of cough, sore throat and/or rhinitis, or when the GP has another reason to suspect COVID-19;
•Is able and willing to comply with all study requirements;
•Participant or legal guardian(s) of a child is able and willing to give informed consent;
•Availability of a freezer at the practice, patient’s home, or a laboratory location to be reached within 1 hour.
•Patients with symptoms of earache only;
•Patients who do not master the national language or are otherwise not able to participate in follow-up procedures;
•Patients who are terminally ill;
•Patients tested positive for SARS-CoV-2 prior to recruitment.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The proportion of COVID-19 in patients presenting with CA-ARTI in primary care
- Secondary Outcome Measures
Name Time Method 1) The clinical presentation and management of patients with CA-ARTI by their GP in primary care during the COVID-19 pandemic and insight in differences in these aspects between European countries<br>2) Risk factors for acquiring COVID-19<br>3) Risk factors of an adverse outcome in patients with COVID-19 in primary care<br>4) Self-management of patients with CA-ARTI during COVID-19 pandemic and insight in differences in these aspects between European countries